Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FL1W7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $75,319
Award facts
- Contract value 100% obligated
- $75,318.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 3, 2025, by the Defense Logistics Agency (DLA) for the supply of Exparel 266 mg/20 mL vials. The contract is valued at $75,318.90 and carries a firm fixed-price structure with an ultimate completion date of September 24, 2025. This delivery order was issued without a set-aside designation, demonstrating the company's competitive standing in federal pharmaceutical procurement. The place of performance is located in Park Ridge, Illinois, where DMS maintains its operations.
This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a single-award vehicle valued at $499,999,999 and valid through November 2026. This IDC framework enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting military health facilities worldwide, including branded and generic prescription drugs, biologics, and specialty medications. Exparel, a liposomal bupivacaine formulation, is utilized as a long-acting local anesthetic for surgical and post-operative pain management, reflecting the company's role as a critical supplier within the federal pharmaceutical supply chain serving Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FL1W7?
SPE2DB25FL1W7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FL1W7 worth?
The government has obligated $75,319 on SPE2DB25FL1W7.
Is contract SPE2DB25FL1W7 an order under another contract?
Yes. SPE2DB25FL1W7 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL1W7 competed?
The extent of competition for SPE2DB25FL1W7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award